ClinicalTrials.Veeva

Menu

Apoptic Biomarkers of Periodontal Disease

University of Michigan logo

University of Michigan

Status

Completed

Conditions

Periodontitis

Treatments

Other: collection of gingival crevicular fluid

Study type

Observational

Funder types

Other

Identifiers

NCT00569075
2004-04

Details and patient eligibility

About

The goal of this study is to facilitate early diagnosis of gum disease. Proteins associated with cell death will be isolated from gum pockets of diseased and healthy patients and evaluated.

Full description

Early detection of the progression of periodontitis is difficult because it typically relies on comparisons of clinical measurements made with a calibrated probe and nonstandardized radiographs over time. Both methods detect periodontal breakdown only after it has occurred. Therefore, considerable emphasis has been placed on identifying more specific and sensitive methods to diagnose and detect periodontal disease progression. The overall goal of this project is to determine whether specific apoptosis-associated proteins, specifically fibronectin (FN) fragments, caspase-3, soluble Fas, and soluble Fas ligand, sampled from gingival crevicular fluid (GCF) can be used as markers for periodontal disease progression.

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adults over age of 18
  • Healthy or diagnosis of periodontitis

Exclusion criteria

  • Active treatment with anti-inflammatory agents such as NSAIDs or steroids and pregnant females

Trial design

60 participants in 2 patient groups

High Risk
Description:
High risk disease prone population
Treatment:
Other: collection of gingival crevicular fluid
Low Risk
Description:
Low risk disease population
Treatment:
Other: collection of gingival crevicular fluid

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems